N-phenyl-N′-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents.: Part 2:: Role of ω-hydroxyl group in the covalent binding to β-tubulin

被引:19
|
作者
Fortin, Sebastien [1 ]
Moreau, Emmanuel [1 ]
Patenaude, Alexandre [1 ]
Desjardins, Michel [1 ]
Lacroix, Jacques [1 ]
Rousseau, Jean L. C. [1 ]
C-Gaudreault, Ren [1 ]
机构
[1] Univ Laval, Hop St Francois Assise, Ctr Rech, Unit Biotechnol & Bioingn, Quebec City, PQ G01L 3L5, Canada
关键词
phenyl chloroethylurea; antimicrotubule agents; antitubulin agents; antimitotic agents; soft alkylating agents; anticancer drugs; colchicine-binding site ligands;
D O I
10.1016/j.bmc.2006.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tubulin is the target of many anticancer drugs, including N-phenyl-N-(2-chloroethyl)urea (CEU). Unlike most anti-beta-tubulin agents, CEUs are protein monoalkylating agents binding through their N'-(2-chloroethyl)urea moiety to an amino acid nearby the colchicine- binding site on beta-tubulin isoform-2. Following the previously synthesized and attractive N'-(3-co-hydroxyalkylphenyl)-N'-(2-chloroethyl)urea that exhibited growth inhibitory activity at the nanomolar level, we investigated the importance of lower alkyl and alkoxy groups to evaluate the effect of hydroxylated group and chain length on both cell growth inhibition and the mechanism of action of CEU. Here, we describe the preparation of two new series of CEU and show that the most potent CEU derivatives beside the co-hydroxylated If were 2f and 3e, respectively. We have confirmed that the pentyl substituted CEUs if, 2f, and 3e are still covalently binding to beta-tubulin and still arrest cell division in G(2)/M phase. Crown Copyright (c) 2006 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1430 / 1438
页数:9
相关论文
共 31 条
  • [21] Synthesis and biological evaluation of novel N-phenyl ureidobenzenesulfonate derivatives as potential anticancer agents. Part 2. Modulation of the ring B
    Gagne-Boulet, Mathieu
    Moussa, Hanane
    Lacroix, Jacques
    Cote, Marie-France
    Masson, Jean-Yves
    Fortin, Sebastien
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 103 : 563 - 573
  • [22] 2-amino-2-oxazolines, part 9:: Synthesis and pharmacological evaluation of N-phenyl-N′-[1-[3-(1-aryl-4-piperazinyl)propan-2-ol]]ureas
    Bosc, JJ
    Jarry, C
    ARCHIV DER PHARMAZIE, 1998, 331 (09) : 291 - 293
  • [23] Synthesis and cytotoxic activity of N-(2-pyridylsulfenyl)urea derivatives.: A new class of potential antineoplastic agents.
    Gil, MJ
    Mañú, MA
    Arteaga, C
    Migliaccio, M
    Encío, I
    González, A
    Martínez-Merino, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2321 - 2324
  • [24] SYNTHESIS OF POTENTIAL ANTICANCER AGENTS .1. NITROGEN MUSTARDS DERIVED FROM PARA-[N,N-BIS(2-CHLOROETHYL)AMINO]BENZALDEHYDE
    ELDERFIELD, RC
    COVEY, IS
    GEIDUSCHEK, JB
    MEYER, WL
    ROSS, AB
    ROSS, JH
    JOURNAL OF ORGANIC CHEMISTRY, 1958, 23 (11): : 1749 - 1753
  • [25] POTENTIAL ANTICANCER AGENTS .V. NEW AROMATIC NITROGEN NUSTARDS RELATED TO 3-[N,N-BIS(2-CHLOROETHYL)AMINO]-4-METHYLBENZOIC ACID
    CAMBANIS, A
    DOBRE, V
    NICULESC.I
    JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (01) : 161 - &
  • [26] The synthesis of N-[substituted phenyl (pyridyl) carbonylamino]-1,2,3,6-tetrahydropypidines as potential anti-inflammatory and hyperglycemic agents.
    Redda, KK
    Yoon, KJ
    Wilson, TL
    Onubogu, UC
    Eckford, TS
    Williams, SL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 134 - MEDI
  • [27] ANTINEOPLASTIC AGENTS .4. LACK OF ACTIVITY OF 3-ALPHA-HYDROXY-17A-AZA-D-HOMO-5-ALPHA-ANDROSTAN-17-ONE P-[N,N-BIS(2-CHLOROETHYL)AMINO]PHENYLA-CETATE, AGAINST SARCOMA 180
    DALMASES, P
    GOMEZBELINCHON, JI
    BONET, JJ
    GINERSOROLLA, A
    SCHMID, FA
    AFINIDAD, 1984, 41 (391) : 272 - 273
  • [29] New hypoglycemic agents -: Part XVI:: Synthesis and evaluation of N3-aryl-N1-[4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazine-2-yl) acetic acid hydrazidosulphonyl]phenyl]ureas/thioureas
    Reddy, RR
    Reddy, TM
    Reddy, VM
    INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 1998, 7 (03) : 185 - 188
  • [30] Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 4:: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes
    Finke, PE
    Oates, B
    Mills, SG
    MacCoss, M
    Malkowitz, L
    Springer, MS
    Gould, SL
    DeMartino, JA
    Carella, A
    Carver, G
    Holmes, K
    Danzeisen, R
    Hazuda, D
    Kessler, J
    Lineberger, J
    Miller, M
    Schleif, WA
    Emini, EA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2475 - 2479